Agilent, DaVita, JDS Uniphase, New York Times, Union: U.S. Equity Movers
Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York.
Agilent Technologies Inc. (A) rose 9.2 percent, the most in the Standard & Poor’s 500 Index, to $46.75. The world’s biggest maker of scientific-testing equipment increased its long-term sales and operating margin forecasts at a meeting with analysts yesterday, JPMorgan Chase & Co. said in a note to clients.
JDS Uniphase Corp. (JDSU) , which bought Agilent’s network solutions test unit last year, climbed 8.9 percent to $27.37, the second-biggest gain in the Standard & Poor’s 500.
Cadence Pharmaceuticals Inc. (CADX) rallied 15 percent, the most since March 2009, to $8.62. The San Diego-based biopharmaceutical company reported a loss of 33 cents a share in the fourth quarter, 1 cent narrower than the average analyst estimate in a Bloomberg survey.
Central European Distribution Corp. (CEDC) fell 8.3 percent to $12.79 for the second-biggest retreat in the Russell 1000 Index. Credit Suisse Group AG downgraded the vodka maker to “underperform” from “outperform,” while Moody’s Investors Service said it may lower the company’s debt rating.
Cerus Corp. (CERS) dropped 14 percent, the most since Nov. 10, to $2.90. The company, which develops systems designed to enhance the safety of blood transfusions, reported fourth- quarter revenue of $6.46 million, trailing the average analyst estimate by 15 percent, Bloomberg data show. Robert W. Baird & Co. cut the stock to “neutral” from “outperform.”
Cooper Cos. (COO US) advanced 10 percent to $70.10 for the biggest increase in the Russell 1000 Index. The maker of contact lenses and medical devices posted quarterly earnings excluding some items that exceeded the average analyst estimate by 26 percent, Bloomberg data show.
DaVita Inc. (DVA) gained 3.7 percent to $83.76, the highest price since at least October 1995. Health-care advisory firm Marwood Group said the Centers for Medicare & Medicaid Services is in the final stage of revising “transition adjustment to budget neutrality” as end-stage renal disease payments move to bundled system.
Kodiak Oil & Gas Corp. (KOG) declined 4.6 percent to $6.98, the lowest price since Feb. 23. The oil and natural gas explorer in the western U.S. posted revenue that fell short of analyst forecasts.
LSB Industries Inc. (LXU) rose 13 percent to $36.28, the highest price since at least 1980. The maker of chemical and climate control products reported fourth-quarter profit of 79 cents a share, more than double the average analyst estimate in a Bloomberg survey.
Madison Square Garden Inc. (MSG) slipped 5.4 percent, the most since July 8, to $28.10. The owner of the New York Knicks reported fourth-quarter profit that missed analysts’ estimates. Miller Tabak Co. cut the stock’s rating to “neutral” from “buy.”
Marvell Technology Group Ltd. (MRVL) had the biggest loss in the Russell 1000 Index, sliding 12 percent to $16.13. The maker of the processor that runs BlackBerry smartphones announced fourth-quarter adjusted earnings and revenue that missed estimates.
Monster Worldwide Inc. (MWW) slipped 6.4 percent to $15.90 for the biggest decline in the S&P 500 Index. The online- recruiting company was cut to “market perform” from “outperform” at William Blair & Co.
New York Times Co. (NYT) sank 5.7 percent, the most since Sept. 22, to $10.24. Lazard Capital Markets Ltd. analyst William Bird initiated coverage of the newspaper owner with a “sell” rating, citing increasing pressure in print as advertising shifts online.
Rival Gannett Co. (GCI US) slipped 2.6 percent to $16.24.
Spreadtrum Communications Inc. (SPRD) rose 6.7 percent, the most since Nov. 2, to $23.07. The Chinese maker of mobile- phone chips reported fourth-quarter sales of $126.5 million, beating the average analyst estimate of $123.4 million in a Bloomberg survey.
Union Drilling Inc. (UDRL) climbed 28 percent, the most since October 2008, to $9.70. The contract-drilling service provider reported fourth-quarter adjusted loss was 4 cents, beating the 11-cent loss average estimate by analysts.
Gabelli & Co. raised its recommendation on the Fort Worth, Texas-based company to a “buy” from “hold.”
USA Mobility Inc. (USMO) slipped 6 percent to $13.43, the lowest price since Aug. 13. The provider of wireless messaging services said it acquired Amcom Software Inc. for $163.3 million.
Vivus Inc. (VVUS) fell 9.4 percent to $6.39, the lowest price since Nov. 26. U.S. regulators said there was a risk of birth defects from the drug topiramate, one ingredient in the company’s experimental weight-loss drug Qnexa.
To contact the reporter on this story: Inyoung Hwang in New York at firstname.lastname@example.org
To contact the editor responsible for this story: Nick Baker at email@example.com